scispace - formally typeset
B

Braden E. Boone

Researcher at Vanderbilt University

Publications -  38
Citations -  5958

Braden E. Boone is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Gene & Exome sequencing. The author has an hindex of 24, co-authored 37 publications receiving 4997 citations. Previous affiliations of Braden E. Boone include University of Manchester & Rice University.

Papers
More filters
Journal ArticleDOI

Patterns and rates of exonic de novo mutations in autism spectrum disorders

TL;DR: Results from de novo events and a large parallel case–control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors and support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold.
Journal ArticleDOI

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

Elizabeth T. Cirulli, +70 more
- 27 Mar 2015 - 
TL;DR: A moderate-scale sequencing study aimed at increasing the number of genes known to contribute to predisposition for ALS found several known ALS genes were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was identified as an ALS gene.
Journal ArticleDOI

Exome sequencing supports a de novo mutational paradigm for schizophrenia.

TL;DR: A comparison to rare inherited variants indicated that the identified de novo mutations show a large excess of non-synonymous changes in schizophrenia cases, as well as a greater potential to affect protein structure and function.
Journal ArticleDOI

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Aude Nicolas, +435 more
- 21 Mar 2018 - 
TL;DR: Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia and Charcot-Marie-Tooth type 2.
Journal ArticleDOI

De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia

TL;DR: It is shown that de novo mutations affect genes with diverse functions and developmental profiles, but it is also found a substantial contribution of mutations in genes with higher expression in early fetal life.